Home/Filings/4/0001079973-10-000735
4//SEC Filing

Buckland Andrew J 4

Accession 0001079973-10-000735

CIK 0001006028other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 6:30 PM ET

Size

12.3 KB

Accession

0001079973-10-000735

Insider Transaction Report

Form 4
Period: 2010-06-28
Buckland Andrew J
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2010-06-28$0.85/sh+141,666$120,41647,609 total
  • Sale

    Common Stock

    2010-06-28$2.86/sh40,000$114,25247,609 total
  • Sale

    Common Stock

    2010-06-30$2.53/sh20,000$50,63447,609 total
  • Exercise/Conversion

    Stock Option

    2010-06-28141,6660 total
    Exercise: $0.85From: 2005-08-02Exp: 2010-08-02Common Stock (141,666 underlying)
  • Sale

    Common Stock

    2010-06-29$2.56/sh40,000$102,34447,609 total
Footnotes (2)
  • [F1]Pursuant to Rule 10b-5 Plan
  • [F2]Incorporates all transactions being reported on this Form 4.

Issuer

PURE BIOSCIENCE

CIK 0001006028

Entity typeother

Related Parties

1
  • filerCIK 0001332290

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 6:30 PM ET
Size
12.3 KB